Celularity (CELUW) Cost of Revenue (2020 - 2025)

Celularity (CELUW) has 6 years of Cost of Revenue data on file, last reported at $7.4 million in Q4 2025.

• Cost of Revenue for Q4 2025 came in at $7.4 million, changed 0.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.1 million (up 33.92% YoY), and the FY2025 annual result was $20.1 million, up 33.92% from the prior year.
• Cost of Revenue rose to $7.4 million in Q4 2025 per CELUW's latest filing, from $3.9 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $9.6 million in Q4 2023 and troughed at $425000.0 in Q2 2022.
• A 5-year average of $3.2 million and a median of $2.7 million in 2021 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue jumped 927.4% in 2021, then slipped 25.57% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $2.8 million in 2021, then soared by 50.5% to $4.2 million in 2022, then surged by 129.83% to $9.6 million in 2023, then decreased by 23.58% to $7.3 million in 2024, then increased by 0.42% to $7.4 million in 2025.
• Business Quant data shows CELUW's Cost of Revenue at $7.4 million in Q4 2025, $3.9 million in Q3 2025, and $5.2 million in Q2 2025.